WELL, GOOD: New Cancer Drug Gets Dramatic Results. “An experimental drug designed to block the effects of a genetic mutation often found in patients with malignant melanoma, a deadly cancer with few existing treatments, significantly shrank tumors in about 80 percent of those who carried the mutation. The findings, published Wednesday in the New England Journal of Medicine, signal a major success for so-called targeted cancer therapies, which are designed to block the effects of genetic mutations that drive the growth of cancer cells.” Faster, please. Hope the FDA won’t, you know, ban it because it might cost money or something.